Lori E. Dodd
National Institute of Allergy and Infectious Diseases(US)
Publications by Year
Research Areas
Statistical Methods in Clinical Trials, Tuberculosis Research and Epidemiology, Health Systems, Economic Evaluations, Quality of Life, Infectious Diseases and Tuberculosis, COVID-19 Clinical Research Studies
Most-Cited Works
- → New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)(2008)28,927 cited
- → Remdesivir for the Treatment of Covid-19 — Final Report(2020)7,674 cited
- → The Lung Image Database Consortium (LIDC) and Image Database Resource Initiative (IDRI): A Completed Reference Database of Lung Nodules on CT Scans(2011)2,692 cited
- → Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19(2020)1,899 cited
- → A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics(2019)1,579 cited
- → Partial AUC Estimation and Regression(2003)348 cited
- → Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure(2016)305 cited
- → A Cautionary Note on the Robustness of Latent Class Models for Estimating Diagnostic Error without a Gold Standard(2004)208 cited
- → Frequency, Severity, and Prediction of Tuberculous Meningitis Immune Reconstitution Inflammatory Syndrome(2012)181 cited
- → Blinded Independent Central Review of Progression-Free Survival in Phase III Clinical Trials: Important Design Element or Unnecessary Expense?(2008)175 cited